Finance

Lists
Why is LLY80 up ၃.၅၂%?
Dive Deeper
LLY80:BKK
Eli Lilly And Company KTB DR
၂.၀၆ ฿
+၃.၅၂%
(+၀.၀၇၀) 1D
အောက် ၁၅, GMT+၇ ၀၁:၀၇:၃၆  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for LLY80...
Open
၁.၉၆ ฿
High
၂.၀၀ ฿
Low
၁.၉၅ ฿
Mkt. cap
ဋေ ၁.၁၄ သိန်း
Avg. vol.
၅.၁၂ သန်း
Volume
၂.၇၄ သန်း
52-wk high
၂.၁၂ ฿
52-wk low
၁.၂၇ ฿
Shares outstanding
၉၄.၁၄ ကုဋေ
No. of employees
၅ သောင်း
Open
၁.၉၆ ฿
High
၂.၀၀ ฿
Low
၁.၉၅ ฿
Mkt. cap
ဋေ ၁.၁၄ သိန်း
Avg. vol.
၅.၁၂ သန်း
Volume
၂.၇၄ သန်း
52-wk high
၂.၁၂ ฿
52-wk low
၁.၂၇ ฿
Shares outstanding
၉၄.၁၄ ကုဋေ
No. of employees
၅ သောင်း
News stories
From web sources and news partners
Barron's
Barron's
·
ပြီးခဲ့သည့် ၅၂ မိနစ်
Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today.
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၁ နာရီ
Lilly’s Tersolisib Food‑Effect Study Marks Quiet But Important Pipeline Progress
Timothy Sykes
Timothy Sykes
·
ပြီးခဲ့သည့် ၁ နာရီ
Eli Lilly (LLY) Extends Obesity Drug Lead As Wall Street Turns More Bullish
StocksToTrade
StocksToTrade
·
ပြီးခဲ့သည့် ၁ နာရီ
LLY Stock Powers Higher As Obesity And Diabetes Pipeline Deepens
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company KTB DR
CEODavid A. Ricks
Employees၅ သောင်း
Founded၁၈၇၆
Headquartersအင်ဒီယားနားပိုလီးစ်, အင်ဒီယားနားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitelilly.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၇၆ ထ
ဋေ ၁.၉၃ ထ
ဋေ ၁.၉၈ ထ
ဋေ ၂.၃၀ ထ
Cost of goods sold
၃၀၀.၈၃ ဋေ
၃၃၇.၁၇ ဋေ
၃၅၇.၇၀ ဋေ
၃၂၆.၈၀ ဋေ
Cost of revenue
၃၀၀.၈၃ ဋေ
၃၃၇.၁၇ ဋေ
၃၅၇.၇၀ ဋေ
၃၂၆.၈၀ ဋေ
Research and development expenses
၃၄၆.၅၇ ဋေ
၃၈၀.၁၅ ဋေ
၃၅၁.၀၀ ဋေ
၃၈၁.၉၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၆၂.၆၇ ဋေ
၃၄၅.၇၅ ဋေ
၂၉၃.၄၀ ဋေ
၃၄၃.၀၀ ဋေ
Operating expense
၆၀၉.၂၄ ဋေ
၇၂၅.၉၀ ဋေ
၆၄၄.၄၀ ဋေ
၇၂၄.၉၀ ဋေ
Total operating expenses
၉၁၀.၀၇ ဋေ
ဋေ ၁.၀၆ ထ
ဋေ ၁.၀၀ ထ
ဋေ ၁.၀၅ ထ
Operating income
၈၅၀.၀၁ ဋေ
၈၆၆.၁၃ ဋေ
၉၇၇.၈၀ ဋေ
ဋေ ၁.၂၅ ထ
Other non operating income
-၉.၁၀ သန်း
၁၈.၁၂ ကုဋေ
၁၇.၀၀ ကုဋေ
၅၆.၁၀ ကုဋေ
EBT including unusual items
၇၂၃.၂၄ ဋေ
၈၂၆.၆၂ ဋေ
၈၈၅.၀၀ ဋေ
၉၂၄.၇၀ ဋေ
EBT excluding unusual items
၈၂၀.၆၁ ဋေ
၈၈၉.၃၂ ဋေ
၉၇၁.၃၀ ဋေ
ဋေ ၁.၂၇ ထ
Income tax expense
၁၆၄.၉၉ ဋေ
၁၆၂.၈၅ ဋေ
၁၄၅.၄၀ ဋေ
၂၁၅.၂၀ ဋေ
Effective tax rate
၂၂.၈၁%
၁၉.၇၀%
၁၆.၄၃%
၂၃.၂၇%
Other operating expenses
-
-
-
-
Net income
၅၅၈.၂၅ ဋေ
၆၆၃.၇၇ ဋေ
၇၃၉.၆၀ ဋေ
၇၀၉.၅၀ ဋေ
Net profit margin
၃၁.၇၂%
၃၄.၄၁%
၃၇.၃၆%
၃၀.၈၈%
Earnings per share
၇.၀၂
၇.၅၄
၈.၅၅
၈.၃၈
Interest and investment income
၆.၅၀ ကုဋေ
၆၇.၂၄ ကုဋေ
-
-
Interest expense
-၁၇.၉၆ ကုဋေ
-၁၅.၃၃ ကုဋေ
-၃၃.၂၀ ကုဋေ
-၃၄.၅၀ ကုဋေ
Net interest expenses
-၁၁.၄၆ ကုဋေ
၅၁.၉၁ ကုဋေ
-၃၃.၂၀ ကုဋေ
-၃၄.၅၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၈၉၇.၀၁ ဋေ
၉၂၄.၇၀ ဋေ
ဋေ ၁.၀၃ ထ
ဋေ ၁.၃၀ ထ
Gain or loss from assets sale
-
-၁၈.၀၀ ကုဋေ
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ